C-peptide and metabolic outcomes in trials of disease modifying therapy in new-onset type 1 diabetes: an individual participant meta-analysis
Peter Taylor(University Hospital of Wales), Jan Dutz(BC Children's Hospital), Peter Senior(University of Alberta), Marjana Marinac(Unknown), Carla J. Greenbaum(Society of Interventional Radiology), Colin Dayan(University of Birmingham), Ionut Bebu(George Washington University), Ulf Hannelius, Jay S. Skyler(University of Miami), Barbara H. Braffett, Jeffrey Krisher, Mark Rigby(Riley Hospital for Children), Matthias von Herrath(Novo Nordisk (Denmark)), Gerald T. Nepom(Virginia Mason Medical Center), Elnaz Atabakhsh(Critical Path Institute), Joseph A. Hedrick, Francisco James León Trujillo, Michael J. Haller(University of Florida), Eleanor L. Ramos(Gainesville Obstetrics & Gynecology), Elizabeth T. Jensen(University of North Carolina at Chapel Hill), Anton Lindqvist, Kimberly S. Collins(Indiana University School of Medicine), Christoph Nowak(Karolinska Institutet), Anna Lam(University of Alberta), Esther Latres(Unknown), Diane K. Wherrett, Parth Narendran(University Hospitals Birmingham NHS Foundation Trust), Johnny Ludvigsson(Linköping University), Stephen R. Karpen(Critical Path Institute), Roy W. Beck(Charlottesville Medical Research), Peter A. Gottlieb(University of Colorado Health), Dana Dabelea(Colorado School of Public Health), Gordon C. Weir(Joslin Diabetes Center), Stephen E. Gitelman(University of California, San Francisco), Robert Andrews(University of Exeter), Kevan Harold, Frank Walker(Lyon 1 Université), Salim Jan Mohamed, Claudia Richard, Alejandro Lozano(Critical Path Institute), Antonella Napolitano(University of Modena and Reggio Emilia), Simi Ahmed(Breakthrough T1D)
Cited by 58
Related Papers
Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range
|Diabetes Care|2019|3.8k
International Consensus on Use of Continuous Glucose Monitoring
|Diabetes Care|2017|2k
Burden and Cost of Gastrointestinal, Liver, and Pancreatic Diseases in the United States: Update 2018
|Gastroenterology|2018|1.7k
Global epidemiology of hyperthyroidism and hypothyroidism
|Nature Reviews Endocrinology|2018|1.5k